Article
The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters.
British journal of clinical pharmacology - 1 Sept 2008
Mirdamadi Hossein Z, Sztanek Ferenc, Derdak Zoltan, Seres Ildiko, Harangi Mariann, Paragh György
Abstract excerpt
AIMS: Human serum paraoxonase-1 (PON1) protects lipoproteins against oxidation by hydrolysing lipid peroxides in oxidized low-density lipoprotein, therefore it may protect against atherosclerosis. One of the two common PON1 gene polymorphisms within the PON1 gene is the Q192R, whose prevalence can be estimated by phenotype distribution analysis. The goal of this study was to clarify the role of PON1 phenotypes on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
